BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32884031)

  • 1. Genome-wide association study for circulating fibroblast growth factor 21 and 23.
    Chuang GT; Liu PH; Chyan TW; Huang CH; Huang YY; Lin CH; Lin JW; Hsu CN; Tsai RY; Hsieh ML; Lee HL; Yang WS; Robinson-Cohen C; Hsiung CN; Shen CY; Chang YC
    Sci Rep; 2020 Sep; 10(1):14578. PubMed ID: 32884031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.
    Robinson-Cohen C; Bartz TM; Lai D; Ikizler TA; Peacock M; Imel EA; Michos ED; Foroud TM; Akesson K; Taylor KD; Malmgren L; Matsushita K; Nethander M; Eriksson J; Ohlsson C; Mellström D; Wolf M; Ljunggren O; McGuigan F; Rotter JI; Karlsson M; Econs MJ; Ix JH; Lutsey PL; Psaty BM; de Boer IH; Kestenbaum BR
    J Am Soc Nephrol; 2018 Oct; 29(10):2583-2592. PubMed ID: 30217807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association and Mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly NASH.
    Larsson SC; Michaëlsson K; Mola-Caminal M; Höijer J; Mantzoros CS
    Metabolism; 2022 Dec; 137():155329. PubMed ID: 36208799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of fibroblast growth factors 21 and 23 and α-Klotho with platelet activity measured by platelet volume indices.
    Takeda Y; Fujita S; Ikemoto T; Okada Y; Sohmiya K; Hoshiga M; Ishizaka N
    Clin Chem Lab Med; 2015 Sep; 53(10):1569-74. PubMed ID: 25781694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genome-wide association study for melatonin secretion.
    Liu PH; Chuang GT; Hsiung CN; Yang WS; Ku HC; Lin YC; Chen YS; Huang YY; Lin CH; Li WY; Lin JW; Hsu CN; Hwang JJ; Liao KC; Hsieh ML; Lee HL; Shen CY; Chang YC
    Sci Rep; 2022 May; 12(1):8025. PubMed ID: 35577822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients.
    Yamamoto S; Koyama D; Igarashi R; Maki T; Mizuno H; Furukawa Y; Kuro-O M
    Intern Med; 2020; 59(3):345-355. PubMed ID: 32009088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The single nucleotide polymorphism rs499765 is associated with fibroblast growth factor 21 and nonalcoholic fatty liver disease in a Chinese population with normal glucose tolerance.
    Jiang S; Zhang R; Li H; Fang Q; Jiang F; Hou X; Hu C; Jia W
    J Nutrigenet Nutrigenomics; 2014; 7(3):121-9. PubMed ID: 25359230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Nucleotide Polymorphisms in Close Proximity to the
    Janzi S; González-Padilla E; Najafi K; Ramne S; Ahlqvist E; Borné Y; Sonestedt E
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
    Mirza MA; Alsiö J; Hammarstedt A; Erben RG; Michaëlsson K; Tivesten A; Marsell R; Orwoll E; Karlsson MK; Ljunggren O; Mellström D; Lind L; Ohlsson C; Larsson TE
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):219-27. PubMed ID: 20966399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
    Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
    Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.
    Nakano C; Hamano T; Fujii N; Matsui I; Tomida K; Mikami S; Inoue K; Obi Y; Okada N; Tsubakihara Y; Isaka Y; Rakugi H
    Clin J Am Soc Nephrol; 2012 May; 7(5):810-9. PubMed ID: 22362065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between circulating fibroblast growth factor-23 and age-related cardiovascular-renal parameters in a healthy Chinese population.
    Wang N; Bai X; Jin B; Han W; Sun X; Chen X
    Geriatr Gerontol Int; 2017 Aug; 17(8):1221-1231. PubMed ID: 27427468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Fibroblast Growth Factors 21 and 23 as Biomarkers of Progression in Diabetic Nephropathy in Type 2 Diabetes with Normoalbuminuria.
    El-Saeed AM; El-Mohasseb GF
    Egypt J Immunol; 2017 Jun; 24(2):93-99. PubMed ID: 29528583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
    Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
    Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
    Marsell R; Grundberg E; Krajisnik T; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
    Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Exome-Chip Association Analysis in Chinese Subjects Reveals a Functional Missense Variant of
    Cheung CYY; Tang CS; Xu A; Lee CH; Au KW; Xu L; Fong CHY; Kwok KHM; Chow WS; Woo YC; Yuen MMA; Cherny SS; Hai J; Cheung BMY; Tan KCB; Lam TH; Tse HF; Sham PC; Lam KSL
    Diabetes; 2017 Jun; 66(6):1723-1728. PubMed ID: 28385800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
    Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
    Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipients.
    Baia LC; Van den Berg E; Vervloet MG; Heilberg IP; Navis G; Bakker SJ; Geleijnse JM; Kromhout D; Soedamah-Muthu SS; De Borst MH;
    Nutr Metab Cardiovasc Dis; 2014 Dec; 24(12):1310-6. PubMed ID: 25063539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Variants Associated with Circulating Parathyroid Hormone.
    Robinson-Cohen C; Lutsey PL; Kleber ME; Nielson CM; Mitchell BD; Bis JC; Eny KM; Portas L; Eriksson J; Lorentzon M; Koller DL; Milaneschi Y; Teumer A; Pilz S; Nethander M; Selvin E; Tang W; Weng LC; Wong HS; Lai D; Peacock M; Hannemann A; Völker U; Homuth G; Nauk M; Murgia F; Pattee JW; Orwoll E; Zmuda JM; Riancho JA; Wolf M; Williams F; Penninx B; Econs MJ; Ryan KA; Ohlsson C; Paterson AD; Psaty BM; Siscovick DS; Rotter JI; Pirastu M; Streeten E; März W; Fox C; Coresh J; Wallaschofski H; Pankow JS; de Boer IH; Kestenbaum B
    J Am Soc Nephrol; 2017 May; 28(5):1553-1565. PubMed ID: 27927781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.